09.13.21
OmniActive Health Technologies has appointed Adam Adelmann as its chief commercial officer. Adelmann will be based in OmniActive’s Morristown, NJ office.
“Adam brings a wealth of experience to this position, and I believe he will enable our organization to reach greater heights,” Mark Dewis, CEO of OmniActive, said.
Adelmann has two decades’ experience in leading sales positions in the B2B and industry spaces, and has worked in leadership positions at companies such as Lonza, Capsugel, Air Products, and Pfizer. Adelmann has extensive expertise in business development, strategic growth planning, and driving innovation while building and leading high-performing teams, OmniActive reports. He graduated from West Chester University of Pennsylvania, and has studied at the Wharton School at the University of Pennsylvania.
“I am thrilled to join OmniActive as its chief commercial officer and I look forward to contributing to its growth journey,” Adelmann said. “Their reputation as a quality, science-based company is unparalleled, which is the key to success in this market.”
“Adam brings a wealth of experience to this position, and I believe he will enable our organization to reach greater heights,” Mark Dewis, CEO of OmniActive, said.
Adelmann has two decades’ experience in leading sales positions in the B2B and industry spaces, and has worked in leadership positions at companies such as Lonza, Capsugel, Air Products, and Pfizer. Adelmann has extensive expertise in business development, strategic growth planning, and driving innovation while building and leading high-performing teams, OmniActive reports. He graduated from West Chester University of Pennsylvania, and has studied at the Wharton School at the University of Pennsylvania.
“I am thrilled to join OmniActive as its chief commercial officer and I look forward to contributing to its growth journey,” Adelmann said. “Their reputation as a quality, science-based company is unparalleled, which is the key to success in this market.”
